期刊文献+

外源性Apelin-13对心力衰竭大鼠血浆血管紧张素Ⅱ和肾上腺髓质素的影响 被引量:2

Effect of Exogenous Apelin-13 on Expression of Plasma Angiotensin-Ⅱ and Adrenomedulin in Heart Failure Rats
原文传递
导出
摘要 目的:研究给予外源性Apelin-13治疗对血流动力学、血浆血管紧张素Ⅱ(Angiotensin-Ⅱ,AngⅡ)和肾上腺髓质素(Adrenomedulin,ADM)水平的影响。方法:将50只大鼠随机分为3组:心衰组(n=20)、治疗组(n=20)和正常对照组(n=10),阿霉素(ADR)腹腔注射建立大鼠心衰模型,治疗组给药外源性Apelin-13治疗,检测大鼠血浆AngⅡ和ADM水平(ELISA法)以及血流动力学的水平。结果:心衰组和治疗组血浆AngⅡ和ADM水平比正常对照组增高,但治疗组血浆AngⅡ和ADM水平比心衰组明显降低,治疗组左心室内压最大升降速度(LV±dp/dtmax)、左室最大收缩压(LVESP)比心衰组增高,左室舒张末期压(LVEDP)比心衰组低(P均<0.05)。结论:外源性apelin-13抑制体内的AngⅡ和ADM水平可能对ADR诱导的大鼠心衰有保护作用。 Objective: To study the effect of exogenous apelin-13 on heart failure rats and detected the cardial function and the levels of the plasma AngⅡ(angiotensin-Ⅱ) and ADM(adrenomedulin).Methods: A total of 50 rats were randomly divided into 3 groups including heart failure group(n=20),therapy group(n=20) and normal group(n=10).Rats heart failure models were induced by Adrenomedulin(ADR) injection intraperitoneally.When the models have created,the therapy groups were injected repectively with aplelin-13 for 10 days.Then we detect the cardial function by ELISA and the levels of the plasma Angiotensin-Ⅱ(AngⅡ) and Adrenomedulin(ADM).Results: The plasma AngⅡ and ADM levels of the heart group and the therapy group were significant higher than the normal group,The therapy group's plasma AngⅡ and ADM levels were lower than the heart failure group's.In therapy group,the LV±dp/dtmax and LVESP were higher and LVEDP were lower than those in heart failure group(all P 0.05).Conclusions: The exogenous apelin-13 can protect rat heart failure which induced by ADR probably through inhibiting the levels of plasma AngⅡand ADM.
出处 《现代生物医学进展》 CAS 2011年第8期1464-1466,1453,共4页 Progress in Modern Biomedicine
关键词 APELIN-13 血管紧张素Ⅱ 肾上腺髓质素 Autonomic system Adrenergic Cholinergic Ganglionated plexi Paroxysmal atrial fibrillation
  • 相关文献

参考文献15

  • 1Tatemoto K, M Hosoya, Y Habata, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun,1998, 251(2): 471-476.
  • 2Medhurst AD, CA Jennings, MJ Robbins, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelih[J]. J Neurochem,2003, 84(5): 1162-1172.
  • 3Hosoya M, Y Kawamata, S Fukusumi, et al. Molecular and ffmctional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin [J]. J Biol Chem,2000, 275 (28): 21061-21067.
  • 4Katugampola SD, JJ Maguire, SR Matthewson, et al. Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man [J]. Br J Pharmacol,2001, 132(6): 1255-1260.
  • 5Kawamata Y, Y Habata, S Fukusumi, et al. Molecular properties of apelin: tissue distribution and receptor binding [J]. Biochim Biophys Acta,2001, 1538(2-3): 162-171.
  • 6Katugampola SD, JJ Maguire, RE.Kuc, et al. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identifie- d using novel radioligands and functional role in the human cardiova- scular system[J]. Can J Physiol Pharmacol,2002, 80(5): 369-374.
  • 7Szokodi I, P Tavi, G Foldes, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility[J]. Circ Res, 2002, 91(5): 434-440.
  • 8Chen MM, EA Ashley, DX Deng, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfimction[J]. Circulat- ion, 2003, 108(12): 1432-1439.
  • 9Goetze JP, JF Rehfeld, J Carlsen, et al. Apelin: a new plasma marker of cardiopulmonary disease[J]. Regul Pept, 2006, 133(1-3): 134-138.
  • 10Chong KS, RS Gardner, JJ Morton, et al. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure[J]. Eur J Heart Fail, 2006, 8(4): 355-360.

二级参考文献5

共引文献42

同被引文献36

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部